In vivo suppression of SIV-mediated immune activation by a p38 MAPK inhibitor combined with ART

by A. Aldovini, O. Chaudhary, V. Narayan, R. Veazey
Published 2015-12-01

Novel SHIVs encoding transmitted/founder envs for latency and cure research

by K. Bar, A. Bauer, R. Veazey, H. Li, G. Shaw, F.H. Lee, M. Watkins
Published 2017-12-01

Novel SHIVs encoding transmitted/founder Envs for latency and cure research

by A. Bauer, E. Lindemuth, L. Kuri-Cervantes, H. Li, M. Watkins, W. Ziani, H. Xu, R. Veazey, G. Shaw, K. Bar
Published 2019-12-01

Peripheral blood SIV/HIV originates from infected cells in tissues

by M. Betts, L. Kuri Cervantes, M.B. Pampena, S. Samer, D. Khoury, I. Frank, M. Paiardini, M. Davenport, K. Bar, R. Veazey
Published 2019-12-01

Targeting HIV/SIV infection of CD4+ T follicular helper (Tfh) Cells: BCL6 inhibition represses HIV infection CD4+ T cells and reduces germinal center hyperplasia in rhesus macaque

by Y. Cai, M. Abdel-Mohsen, M. Watkins, F. Xue, Y. AI, H. Cheng, C. Midkiff, C. Tomescu, X. Wang, X. Alvarez, R. Veazey, L. Montaner
Published 2019-07-01

Prolonged, High-Fidelity Simulation for Study of Patient Care in Resource-Limited Medical Contexts and for Technology Comparative Effectiveness Testing

by Jeremy C. Pamplin, MD, FCCM, FACP, Sena R. Veazey, MS, Joanne De Howitt, BS, Katy Cohen, RN, Stacie Barczak, BS, Mark Espinoza, BS, Dave Luellen, BS, MBA, Kevin Ross, BS, PMP, Maria Serio-Melvin, RN, Mary McCarthy, RN, PhD, Christopher J. Colombo, MD, MA, FCCM, FACP
Published 2021-07-01